Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-01

Clinical Trial Update: The COAT Trial: Cequa's Onset of Action Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial named COAT evaluating Cequa's onset of action in dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cequa (cyclosporine ophthalmic solution)

Snippet

Sponsor: Research Insight LLC | Conditions: Dry Eye | Phase 4 | Status: COMPLETED